Top Markets
#1 Derive Derive +30.11%
#2 Audiera Audiera +18.48%
#3 Cross Cross +16.71%
#4 Cap Cap +10.81%
#5 Humanity Humanity +10.71%
#6 The Bitcoin Bull The Bitcoin Bull +10.16%
#7 Biconomy Biconomy +10.09%
#8 Based Based +8.50%
#9 Velvet Velvet +8.28%
#10 Geodnet Geodnet +8.10%
Coin of the day
Derive Derive
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Silo Pharma, Inc. Silo Pharma, Inc.

Silo Pharma, Inc.

SILO
Classifica tra le azioni #35574
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm... Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.
Prezzo delle azioni
$3.29
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$3.71M
Variazione (1 giorno)
2.17%
Variazione (1 anno)
-69.11%
Paese
US
Scambia Silo Pharma, Inc. (SILO)

Categoria

Healthcare
Il prezzo SILO con la capitalizzazione del mercato della B
Silo Pharma, Inc. Silo Pharma, Inc.
SILO
$3.29
Capitalizzazione di mercato di Silo Pharma, Inc.(SILO)
Capitalizzazione di mercato: $3.71M
A partire dal August 2026, Silo Pharma, Inc. ha una capitalizzazione di mercato pari a $3.71M. Questo rende Silo Pharma, Inc. la 35574th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Silo Pharma, Inc. dal 2021 al 2026
SILO in paragone con la classifica dei più popolari stocks
Il prezzo per SILO Attivo B Capitalizzazione del mercato a B Risultati
Silo Pharma, Inc. Silo Pharma, Inc.
$4,830,422 $3.71M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +146,821,240.26%
Silo Pharma, Inc. Silo Pharma, Inc.
$3,978,213 $3.71M
Apple Inc. Apple Inc.
AAPL
$4.490T +120,918,236.84%
Silo Pharma, Inc. Silo Pharma, Inc.
$3,687,944 $3.71M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +112,095,461.94%
Silo Pharma, Inc. Silo Pharma, Inc.
$3,257,285 $3.71M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +99,005,516.16%
Silo Pharma, Inc. Silo Pharma, Inc.
$2,510,111 $3.71M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +76,295,058.95%